Pay in 4 interest-free payments of $5.70 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
Phase 1 and phase 2a, first-in-human (FIH) study, of DRP-104, a broad glutamine antagonist, in adult patients with advanced solid tumors
Additionally, many manufacturers provide regulatory support, helping brands navigate the complex requirements for supplement marketing and distribution in various jurisdictions
Your fitness goal decides the right supplement
Klusa VZ, Isajevs S, Svirina D, Pupure J, Beitnere U, Rumaks J, Svirskis S, Jansone B, Dzirkale Z, Muceniece R, Kalvinsh I, Vinters HV (2010) Neuroprotective properties of mildronate, a small molecule, in a rat model of Parkinson's disease
US$ 20.14
US$ 24.36
US$ 24.39
US$ 20.20
US$ 23.11
US$ 22.93
US$ 28.35
US$ 20.27
US$ 28.07
US$ 25.25
